RIDE vs SUPN
RIDE (RIDE) versus Supernus Pharmaceuticals Inc (SUPN) — a side-by-side from cached financials, not a winner call.
RIDE (RIDE) common stock.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
RIDE does not have a complete income-statement cache yet.
Latest reported SUPN revenue for 2026-06-30 was $426.8M. Net income was -$60.7M. SUPN currently screens at market cap $2.53B.
SUPN currently screens at market cap $2.53B.
Not investment advice. Open the RIDE and SUPN stock pages for the full models.
Not investment advice.